Navigation Links
Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
Date:4/22/2010

HARLEYSVILLE, Pa., April 22 /PRNewswire/ -- Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm.  This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS® sugar spheres complements Colorcon's SureSpheres® sugar spheres product line and barrier membrane systems for multiparticulates.  Colorcon will now have two production facilities for sugar spheres offering critical business continuity planning for their customer base.  ETHISPHERES® microcrystalline cellulose pellets, NPTAB® neutral pellets for direct compression, and other excipient products are also added to the Colorcon product portfolio as a result of this acquisition.

The headquarters and main production facilities of NP Pharm, located in Bazainville, France, will become an integral part of the Colorcon network of manufacturing sites.

William Motzer, Colorcon Chief Executive Officer states, "We are excited about this opportunity to expand Colorcon's product offerings and leverage our global distribution, technical service and sales infrastructure."

Newly appointed Chairman and CEO of the Management Board of Ethypharm, Hugues Lecat states, "We are delighted to see NP Pharm join Colorcon, Inc.  The new shareholder will permit NP Pharm to reinforce its development and growth projects.  This divestiture will enable us to go on investing in the growth of Ethypharm, in line with our strategy.  Ethypharm will continue to invest in its R&D sites, notably that of Grand Quevilly, France, our most recent state-of-the-art manufacturing plant, in which we have invested over 15 million Euros over the last two years."

About Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

About Ethypharm

Ethypharm is one of the leading pharmaceutical companies dedicated to the development of innovative medicines.  Its patented technologies offer multiple benefits for patients by improving efficacy, administration, compliance, and reducing side-effects. Ethypharm provides its clients with solutions for the life cycle management of their drugs. The company has one of the broadest portfolios of technologies to become the worldwide privileged partner of pharmaceutical companies. Ethypharm offers customized solutions for the development of the medicines of the future.


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
3. Cambrex Acquires IEP GmbH
4. Essilor Acquires FGX International, Becoming a Major Player in a New Fast-Growing Market
5. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
6. Bioniche Pharma Acquires Seven New Products From GeneraMedix Inc.
7. STD Med Inc. Acquires Facility for Manufacturing and Start-Ups
8. PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group
9. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
10. Advanced Health Media Acquires Advogent
11. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Getting enough sleep affects much more than energy ... going just 19 hours without sleep can compromise motor reaction time, which can increase the ... Amica Insurance is sharing the following tips from the NSF to help you sleep better ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has published a new post that ... Yisrayl says with so many titles and names for the Creator, it’s hard for many ... Scripture, backed with a lot of research, the truth is undeniable. , “If you ...
(Date:4/28/2017)... York, New York (PRWEB) , ... April 28, ... ... high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin ... cream provides the hydrating benefits of a moisturizer with the power of an ...
Breaking Medicine News(10 mins):